-
-
Login
Novo Nordisk is adopting the shorter name ‘Novo’ as part of a major global rebrand. Behind the new logo is a wider shift in how one of diabetes’s oldest companies sees healthcare, patients and an increasingly consumer-driven market.
NICE has backed once-weekly insulin efsitora alfa, branded Onswik, for type 2 diabetes manangement. It could mean 313 fewer basal injections a year, fewer needles and less pressure on injection sites, while delivering glucose control comparable with daily insulin.
For years, type 2 diabetes has been linked to carrying too much body fat. But new research suggests the story may be more complicated. According to scientists, it's not just how much fat you have that matters. It's whether your body can still use it properly.
